menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Multiple Myeloma: Current Treatment Modalities

close
Multiple Myeloma: Current Treatment Modalities
RestartResume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients. How can we determine which patients are viable candidates for a specific treatment regimen? Dr. James Berenson, founding president and chief executive officer of the Institute for Myeloma and Bone Cancer Research in West Hollywood, Calif., probes these issues and more with host Dr. Mark Nolan Hill.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients. How can we determine which patients are viable candidates for a specific treatment regimen? Dr. James Berenson, founding president and chief executive officer of the Institute for Myeloma and Bone Cancer Research in West Hollywood, Calif., probes these issues and more with host Dr. Mark Nolan Hill.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 2/26/20